Biomarker signatures of sickle cell disease severity

Main|Search|PHGKB



Last Posted: May 24, 2018

---

• Biomarker signatures of sickle cell disease severity.  
  Du Mengtian et al. Blood cells, molecules & diseases 2018 May
• The impact of real-world cardiovascular-related pharmacogenetic testing in an insured population.  
  Billings Jennifer et al. International journal of clinical practice 2018 May e13088
• Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtype  
  MS Udler et al, BioRXIV, May 2018
• A “Prime Example” of How Stroke Can Happen to Anyone 
• Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation.  
  Hall Angela et al. Cardiovascular & hematological disorders drug targets 2017 17(1) 58-63
• Challenges and Opportunities in Stroke Genetics.  
  Malik Rainer et al. Cardiovascular research 2018 Mar
• Genetics and Family History Can Increase Risk for Stroke 
• Genome Culture: A Personal Risk Score May Be the Next Big Thing in Genetic Medicine  
  L Hercher, Genome Magazine, Apr 2018
• National Stroke Awareness Month 2018: Stroke Can Happen to Anyone at Any Time  
  Focus on increasing awareness among adults ages 35 to 64 of stroke risk factors, signs, and symptoms
• Infinitesimal Odds: A Scientist Finds Her Child’s Rare Illness Stems From the Gene She Studies  
  P Belluck, NY Times, Apr 23, 2018

more